Inborn errors of adrenal steroidogenesis

Molecular and Cellular Endocrinology

Volumn 211, Issue 1-2, 2003, Pages 75-84

  New, Maria I ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

11 Hydroxylase; 17 Hydroxylase 17,20 lyase; 21 Hydroxylase; 3 Hydroxysteroid dehydrogenase; Cholesterol desmolase; Congenital adrenal hyperplasia; Congenital lipoid adrenal hyperplasia; Steroidogenesis acute regulatory protein

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); STEROID 11BETA MONOOXYGENASE; STEROID 17,20 LYASE; STEROID 17ALPHA MONOOXYGENASE; STEROID 21 MONOOXYGENASE;

ADRENAL CORTEX; ANDROGEN SYNTHESIS; CLINICAL FEATURE; CONFERENCE PAPER; CONGENITAL ADRENAL HYPERPLASIA; ENZYME DEFICIENCY; GENE MAPPING; GENE MUTATION; HUMAN; HYDROCORTISONE RELEASE; MOLECULAR DYNAMICS; PRIORITY JOURNAL;

EID: 0344084434     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.09.013     Document Type: Conference Paper

References (45)

1. Birnbaum M., Rose L. Late onset adrenocortical hydroxylase deficiencies associated with menstrual dysfunction. Obstet. Gynecol. 63:1984;445-451.
2. Bongiovanni A. Adrenogenital syndrome with deficiency of 3β-hydroxysteroid dehydrogenase. J. Clin. Invest. 41:1962;2086-2092.
3. Bongiovanni, A.M., 1984. Congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase. In: New, M.I., Levine, L.S., (Eds.), Adrenal Diseases in Childhood. Karger, Basel, 1984, pp.72-82.
4. Bongiovanni A.M., Eberlein W.R., Goldman A.S., New M. Disorders of adrenal steroid biogenesis. Recent Prog. Horm. Res. 23:1967;375-449.
5. Bose H., Sugawara T., Strauss J.R., Miller W. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International Congenital Lipoid Adrenal Hyperplasia Consortium. N. Engl. J. Med. 335:1996;1870-1878.
6. Cathelineau G., Brerault J., Fiet W. Adrenocortical 11B-hydroxylation defect in adult women with postmenarchial onset of symptoms. J. Clin. Endocrinol. Metab. 51:1980;287-291.
7. Cerame, B.I., Newfield, R.S., Wilson, R.C., New, M.I., 1999. Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia. In: New, M.I. (Ed.), Diagnosis and Treatment of the Unborn Child. Idelson-Gnocchi Ltd., Reddick, FL, pp.175-178.
8. Chua S., Szabo P., Vitek A., Grzeschik K., John M., White P. Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11). Proc. Natl. Acad. Sci. U.S.A. 84:1987;7193-7197.
9. Clark B., Wells J., King S., Stocco D. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J. Biol. Chem. 269:1994;28314-28322.
10. Clark P. Nonclassic 11 beta-hydroxylase deficiency: report of two patients and review. J. Pediatr Endocrinol. Metab. 13:2000;105-109.
11. Curnow K.M., Slutsker L., Vitek J., Cole T., Speiser P.W., New M.I., White P.C., Pascoe L. Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4552-4556.
12. Dupont B., Oberfield S.E., Smithwick E.M., Lee T.D., Levine L.S. Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet. 2:1977;1309-1312.
13. Eberlein W., Bongiovanni A. Plasma and urinary corticosteroids in the hypertensive form of congenital adrenal hyperplasia. J. Biol. Chem. 223:1956;85-94.
14. Gabrilove J., Sharma D., Dorfman R. Adrenocortical 11B-hydroxylase deficiency and virilism first manifest in the adult woman. N. Engl. J. Med. 272:1965;1189-1194.
15. Hurwitz A., Brautbar C., Milwidsky A. Combined 21- and 11B-hydroxylase deficiency in familial congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 60:1985;631-638.
16. Joehrer K., Geley S., Strasser-Wozak E.M., Azziz R., Wollmann H.A., Schmitt K., Kofler R., White P.C. CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Hum. Mol. Genet. 6:1997;1829-1834.
17. Kenny F., Reynolds J., Green O. Partial 3B-hydroxysteroid dehydrogenase deficiency in a family with congenital adrenal hyperplasia: evidence for increasing 3B-HSD activity with age. Pediatrics. 48:1971;756-765.
18. Krawczak M., Cooper D.N. The human gene mutation database. Trends Genet. 13:2003;121-122.
19. Matteson K., Chung B., Urdea M., Miller W. Study of cholesterol side-chain cleavage (20,22 desmolase) deficiency causing congenital lipoid adrenal hyperplasia using bovine-sequence P450scc oligodeoxyribonucleotide probes. Endocrinology. 118:1986;1296-1305.
20. Matteson K., Picado-Leonard J., Chung B., Mohandas T., Miller W. Assignment of the gene for adrenal P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase) to human chromosome 10. J. Clin. Endocrinol. Metab. 63:1986;789-791.
21. Merke D.P., Tajima T., Chhabra A., Barnes K., Mancilla E., Baron J., Cutler G.B. Jr. Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 83:1998;270-273.
22. Nebert D.W., Nelson D.R., Coon M.J. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol. 10:1991;1-14.
23. New M., Lorenzen F., Lerner A., Kohn B., Oberfield S., Pollack M., Dupont B., Stoner E., Levy D., Pang S., Levine L. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J. Clin. Endocrinol. Metab. 57:1983;320-326.
24. New, M., White, P., Pang, S., Dupont, B., Speiser, P., 1989. The adrenal hyperplasias. In: Scriver, C., Beaudet, A., Sly, W., Valle, D. (Eds.), The Metabolic Basis of Inherited Disease, sixth ed. McGraw-Hill, New York, pp. 1881-1918.
25. New, M.I., Levine, L.S., 1973. Congenital adrenal hyperplasia. In: Harris, H., Hirschhorn, K. (Eds.), Advanced Human Genetics. Plenum Publishers, New York, pp. 251-326.
26. Newmark D., Dluhy R., Williams G., Pochi P., Rose L. Partial 11-hydroxylase and 21-hydroxylase deficiencies in hirsute women. Am. J. Obstet. Gynecol. 127:1977;594-598.
27. Okuyama E., Nishi N., Onishi S., Itoh S., Ishii Y., Miyanaka H., Fujita K., Ichikawa Y. A novel splicing junction mutation in the gene for the steroidogenic acute regulatory protein causes congenital lipoid adrenal hyperplasia. J. Clin. Endocrinol. Metab. 82:1997;2337-2342.
28. Pang S., Levine L.S., Stoner E., Opitz J.M., Pollack M.S., Dupont B., New M.I. Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function. J. Clin. Endocrinol. Metab. 56:1983;808-818.
29. Pang S.Y., Lerner A.J., Stoner E., Levine L.S., Oberfield S.E., Engel I., New M.I. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. Part I. A cause of hirsutism in pubertal and postpubertal women. J. Clin. Endocrinol. Metab. 60:1985;428-439.
30. Pang S.Y., Wallace M.A., Hofman L., Thuline H.C., Dorche C., Lyon I.C., Dobbins R.H., Kling S., Fujieda K., Suwa S. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics. 81:1988;866-874.
31. Porter B., Finzi M., Leiberman E., Moses S. Syndrome of congenital adrenal-hyperplasia in Israel. Pediatrics. 6:1977;100-105.
32. Prader A. Die Häufigkeit des kongenitalen adrenogenitalen Syndromes. Helv. Paediatr. Acta. 13:1958;5-14.
33. Rosler, A., Leiberman, E., 1984. Enzymatic defects of steroidogenesis: 11beta-hydroxylase deficiency congenital adrenal hyperplasia. In: New, M.I., Levine, L.S. (Eds.), Adrenal Diseases In Childhood: Pathophysiologic and Clinical Aspects. S. Karger, Basel, pp. 47-71.
34. Skinner C.A., Rumsby G., Honour J.W. Single strand conformation polymorphism (SSCP) analysis for the detection of mutations in the CYP11B1 gene. J. Clin. Endocrinol. Metab. 81:1996;2389-2393.
35. Sparkes R., Klisak I., Miller W. Regional mapping of genes encoding human steroidogenic enzymes: P450scc to 15q23-q24, adrenodoxin to 11q22; adrenodoxin reductase to 17q24-q25; and P450c17 to 10q24-q25. DNA Cell Biol. 10:1991;359-365.
36. Sugawara T., Holt J., Driscoll D., Strauss J., Lin D., Miller W., Patterson D., Clancy K., Hart I., Clark B. Human steroidogenic acute regulatory protein: functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and a pseudogene to chromosome 13. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4778-4782.
37. Tajima T., Fujieda K., Kouda N., Nakae J., Miller W. Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46, XY sex reversal and adrenal insufficiency. J. Clin. Endocrinol. Metab. 86:2001;3820-3825.
38. Temeck J.W., Pang S.Y., Nelson C., New M.I. Genetic defects of steroidogenesis in premature pubarche. J. Clin. Endocrinol. Metab. 64:1987;609-617.
39. Wagner M., Ge Y., Siciliano M., Wells D. A hybrid cell mapping panel for regional localization of probes to human chromosome 8. Genomics. 10:1991;114-125.
40. Werder E.A., Siebenmann R.E., Knorrmurset W., Zimmermann A., Sizonenko P., Theintz P., Girard J., Zachmann M., Prader A. The incidence of congential adrenal hyperplasia in Switzerland - a survey of patients in 1960 to 1974. Helv. Paediatr. Acta. 35:1980;5-11.
41. White P. Steroid 11 beta-hydroxylase deficiency and related disorders. Endocrinol. Metab. Clin. North Am. 30:2001;61-79. vi.
42. White P.C., New M.I., Dupont B. Congenital adrenal hyperplasia 1. N. Engl. J. Med. 316:1987;1519-1524.
43. Wilkins L., 1957. The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence. 2nd ed. Charles C. Thomas, Springfield, IL, p. 526.
44. Zachmann M., Vollmin W., Hamilton W., Prader A. Steroid 17,20-desmolase deficiency: a new cause of male pseudohermaphroditism. Clin. Endocrinol. 1:1972;369-385.
45. Zachmann M., Werder E., Prader A. Two types of male pseudohermaphroditism due to 17,20-desmolase deficiency. J. Clin. Endocrinol. Metab. 55:1982;487-490.